| AFEGX | VTSAX | AFEGX / VTSAX | |
| Total Expense Ratio | 0.00 | 0.04 | - |
| Annual Report Gross Expense Ratio | 0.44 | 0.04 | 1,100% |
| Fund Existence | 7 years | 25 years | - |
| Gain YTD | 10.739 | 13.952 | 77% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.4B | 2.05T | 0% |
| Annual Yield % from dividends | 1.23 | 1.11 | 111% |
| Returns for 1 year | 2.54 | 11.52 | 22% |
| Returns for 3 years | 50.35 | 66.89 | 75% |
| Returns for 5 years | 66.66 | 80.80 | 83% |
| Returns for 10 years | N/A | 225.71 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WRHIX | 5.93 | -0.01 | -0.17% |
| Macquarie High Income Fund Class C | |||
| NIEYX | 19.49 | -0.13 | -0.66% |
| BNY Mellon International Equity Y | |||
| JVASX | 39.84 | -0.37 | -0.92% |
| JPMorgan Value Advantage I | |||
| AMTOX | 10.42 | -0.11 | -1.04% |
| AB All Market Real Return 1 | |||
| LYFCX | 14.79 | -0.19 | -1.27% |
| AlphaCentric Life Sciences & Hlthcare C | |||